Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib in HIV-associated and HIV-negative Kaposi Sarcoma
NCT04941274Phase 2Recruiting
- Sponsor
- National Cancer Institute
- Start
- Sep 2021
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in Kaposi sarcoma (KS), sponsored by National Cancer Institute. Started Sep 2021; status: recruiting.
02
Drugs
abemaciclib
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT04941274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04941274.